VHAM
TMO icon

Van Hulzen Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Van Hulzen Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-93
Closed -$48.4K – 1038
2024
Q4 		$48.4K Buy
+93
New +$51.1K ﹤0.01% 511
2023
Q4 		– Sell
-461
Closed -$233K – 320
2023
Q3 		$233K Sell
461
-575
-56% -$306K 0.02% 275
2023
Q2 		$541K Buy
1,036
+250
+32% +$135K 0.05% 177
2023
Q1 		$453K Sell
786
-79
-9% -$44.5K 0.04% 189
2022
Q4 		$476K Hold
865
– – 0.05% 180
2022
Q3 		$439K Hold
865
– – 0.05% 178
2022
Q2 		$470K Hold
865
– – 0.06% 172
2022
Q1 		$511K Sell
865
-194
-18% -$111K 0.05% 168
2021
Q4 		$707K Hold
1,059
– – 0.08% 145
2021
Q3 		$605K Hold
1,059
– – 0.09% 127
2021
Q2 		$534K Hold
1,059
– – 0.08% 138
2021
Q1 		$483K Sell
1,059
-204
-16% -$97.4K 0.08% 148
2020
Q4 		$588K Sell
1,263
-51
-4% -$23.9K 0.09% 124
2020
Q3 		$580K Sell
1,314
-2,206
-63% -$911K 0.09% 117
2020
Q2 		$1.27M Buy
3,520
+2,200
+167% +$737K 0.19% 80
2020
Q1 		$374K Hold
1,320
– – 0.08% 146
2019
Q4 		$429K Sell
1,320
-31
-2% -$9.4K 0.08% 167
2019
Q3 		$394K Hold
1,351
– – 0.08% 172
2019
Q2 		$397K Buy
1,351
+154
+13% +$42.4K 0.09% 163
2019
Q1 		$328K Buy
1,197
+36
+3% +$8.96K 0.09% 161
2018
Q4 		$260K Buy
1,161
+31
+3% +$7.27K 0.08% 186
2018
Q3 		$276K Buy
+1,130
New +$260K 0.07% 177

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Van Hulzen Asset Management's TMO Position: Q1 2025 in Review

Van Hulzen Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 93 shares — an estimated $48.4K sold.

Van Hulzen Asset Management first reported a position in TMO in Q3 2018 and held it in 22 quarters. The position peaked at $1.27M in Q2 2020. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Van Hulzen Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Van Hulzen Asset Management sold 93 Thermo Fisher Scientific shares in Q1 2025, an estimated $48.4K.
  • Van Hulzen Asset Management first reported a position in Thermo Fisher Scientific in Q3 2018 and held it in 22 quarters.
  • Van Hulzen Asset Management's Thermo Fisher Scientific position peaked at $1.27M in Q2 2020.
  • 2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Van Hulzen Asset Management's 13F filing for Q1 2025, filed 14 May 2025.